In The News Posted August 21, 2019 Share Posted August 21, 2019 SAN JOSE, Calif., Aug. 21, 2019 /PRNewswire/ -- Shield Diagnostics, an Andreessen Horowitz-backed biotechnology company tackling antibiotic resistance by bringing precision medicine to infectious disease, announced today that it has appointed David Esposito to its Board of Directors. Mr.... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.